Nu Skin Enterprises Sees Notable Reduction in Short Interest

Nu Skin Enterprises, Inc. (NYSE:NUS - Get Free Report) experienced a marked decrease in short interest during December. As of December 31st, the total short interest stood at 1,160,000 shares, reflecting a significant decline of 28.0% from the mid-December figure of 1,610,000 shares. With an average trading volume of 832,300 shares, the short-interest ratio is currently at 1.4 days. This indicates that about 2.4% of the company's shares are currently sold short.

Get Nu Skin Enterprises alerts:

Institutional Trading Activity

Large investors have been adjusting their positions in Nu Skin Enterprises recently. Notably, Pacer Advisors Inc. initiated a new stake in the company during the second quarter, valued at approximately $25,230,000. Furthermore, Federated Hermes Inc. increased its holdings by an impressive 111.8% within the same period, now owning 1,323,542 shares valued at $13,950,000 after gaining an additional 698,722 shares last quarter. Geode Capital Management LLC also raised its stake by 1.1% in the third quarter, now holding 1,130,487 shares worth about $8,333,000 after acquiring another 11,838 shares. In addition, Jane Street Group LLC expanded its position by an astonishing 358.4%, possessing 924,993 shares valued at $6,817,000 following the purchase of 723,220 additional shares. Hotchkis & Wiley Capital Management LLC enhanced its position by 27.7%, bringing its total to 603,555 shares worth $4,448,000 after adding 130,980 shares in the previous quarter. Currently, 82.84% of Nu Skin Enterprises's shares are owned by institutional investors and hedge funds.

Stock Performance Overview

On Friday, shares of NYSE NUS dipped by $0.03 midday, bringing their price to $6.91. The trading volume for the day was 121,994 shares, well below the average volume of 949,696 shares. Over the past year, Nu Skin Enterprises has fluctuated between a low of $5.95 and a high of $19.30. The market capitalization of the company is approximately $343.25 million, with a P/E ratio of -3.32 and a beta of 1.19. The stock’s 50-day moving average stands at $7.18, while its 200-day moving average is $8.02. The company's debt-to-equity ratio is 0.53, indicating manageable levels of debt, with a quick ratio of 1.20 and a current ratio of 1.93, suggesting good short-term financial health.

Latest Dividend Announcement

The company recently declared a quarterly dividend that was disbursed on December 11th. Shareholders recorded on November 29th received a dividend of $0.06 per share, translating to an annualized dividend payout of $0.24, resulting in a yield of 3.48%. The ex-dividend date was also set for November 29th. Currently, Nu Skin Enterprises has a dividend payout ratio of -11.59%, which suggests reinvestment in growth over returning excess cash to shareholders.

Analyst Ratings and Insights

Check Our Latest Stock Analysis on NUS

Company Background

Nu Skin Enterprises, Inc. focuses on developing and distributing a range of beauty and wellness products globally. The company’s offerings include skincare devices, cosmetics, and various personal care items, particularly the ageLOC LumiSpa and ageLOC LumiSpa iO lines, alongside nutricentials skincare products.

Featured Business Topics

• Explore superior stock options to Nu Skin Enterprises
• Understand the Euro STOXX 50 Index
• Discover opportunities in the nuclear energy sector driven by AI demand
• Assess the potential risks of bond ownership
• Analyze TSMC's long-term outlook amid rising geopolitical risks
• Consider home improvement stocks that promise portfolio enhancement
• Review Uber's NVIDIA partnership and buybacks indicating potential upside

This news update was generated using advanced technology, incorporating financial data to ensure timely and precise reporting. This content has been reviewed by an editorial team prior to publication.

Investment Considerations

If you are contemplating an investment of $1,000 in Nu Skin Enterprises, it’s advisable to read further.

Market analytics cover recommendations from top-rated analysts regarding stocks they find appealing currently, including those that outperform Nu Skin Enterprises.

Explore these highlighted stocks now.

NuSkin, ShortInterest, Investors, Performance, Dividends